Published: Apr 11, 2025, 10:10 IST | Updated: Apr 11, 2025, 10:10 IST
In a major medical breakthrough, the NHS has approved Capivasertib for funding in England. Used in combination with hormone therapy, the drug has shown significant promise in clinical trials—shrinking tumours in nearly a quarter of advanced breast cancer patients. This approval brings new hope to thousands battling the disease.